TABLE 2.
Parameter | 2 Weeks | Third Month* | Sixth Month |
---|---|---|---|
CGM data availability, % | 83.0 ± 9.9 | 76.4 ± 17.1 | 79.0 ± 11.7 |
Coefficient of variation, % | 30.1 ± 7.2 | 30.9 ± 6.3 | 30.0 ± 6.6 |
Glucose, mg/dL | 160.4 ± 32.7† | 170.7 ± 38.0 | 166.2 ± 31.8 |
GMI, % | 7.1 ± 0.8† | 7.4 ± 0.9 | 7.3 ± 0.8 |
Percent times in ranges, mg/dL 70–180 >180 181–250 >250 <70 54–69 <54 |
67.3 ± 20.2† 30.8 ± 20.6† 22.7 ± 11.9 8.1 ± 12.6† 1.9 ± 3.1 1.7 ± 2.6 0.2 ± 0.6 |
61.8 ± 20.8 36.6 ± 21.7 24.8 ± 11.3 11.8 ± 15.5 1.6 ± 2.7 1.5 ± 2.4 0.2 ± 0.3 |
64.2 ± 20.3 34.3 ± 20.6 24.7 ± 11.4 9.6 ± 12.4 1.4 ± 2.4 1.3 ± 2.1 0.2 ± 0.4 |
Data are mean ± SD.
One person did not have >50% of CGM data for analysis in the third month; data reflects n = 57.
Friedman test and subsequent pairwise comparisons showed a statistically significant difference of the first 2 weeks compared with the third and sixth months (P <0.05); no other variables were found to be statistically significant using statistics appropriate to the distribution.